In NSCLC, CCT6A is associated with TGFβ downstream transcription factor SMAD2, and inhibition of CCT6A suppresses TGFβ-mediated NSCLC metastasis [29]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.